Madrigal Pharmaceuticals Inc.
MDGL | NASDAQ
$431.15
+$0.79 (+0.18%)
At close: Nov 2, 2026, 4:00 PM ET
$430.38
+$0.02 (0.00%)
Pre-market:
Nov 2, 2026, 9:29 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 364.25M | 311.34M | 321.08M | 287.27M | 212.8M | 137.25M | 103.32M | 62.18M | 14.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 40.01M | 26.85M | 24.45M | 18.12M | 9.07M | 4.51M | 3.45M | 2.15M | 636K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 324.25M | 284.49M | 296.64M | 269.15M | 203.74M | 132.74M | 99.88M | 60.02M | 14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -56.31M | -92.72M | -59.61M | -113.98M | -47.2M | -79.31M | -67M | -116.3M | -162.54M | -152.04M | -117.18M | -98.53M | -86.45M | -78.34M | -85.3M | -80.41M | -70.27M | -57.59M | -64.6M | -63.16M | -61.74M | -52.98M |
Interest Income | 7.1M | 8.24M | 9.46M | 10.31M | 8.23M | 9.37M | 11.08M | 13.02M | 14.22M | 8.33M | 8.95M | 3.3M | 3.55M | 3.78M | 1.08M | 717K | 323K | 69K | 52K | 60K | 91K | 160K |
Pretax Income | -57.94M | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M | -59.42M | -106.96M | -151.97M | -147.54M | -112.19M | -98.74M | -85.8M | -76.9M | -85.91M | -81.2M | -70.73M | -57.52M | -64.55M | -63.1M | -61.65M | -52.55M |
Net Income | -57.94M | -94.39M | -58.58M | -114.19M | -42.28M | -73.24M | -59.42M | -106.96M | -151.97M | -147.54M | -112.19M | -98.74M | -85.8M | -76.9M | -85.91M | -81.2M | -70.73M | -57.52M | -64.55M | -63.1M | -61.65M | -52.55M |
Selling & General & Admin | 289.38M | 268.52M | 239.98M | 209.12M | 196.86M | 167.88M | 141.22M | 107.59M | 105.45M | 80.8M | 46.54M | 27.58M | 17.85M | 16.18M | 14.56M | 12.14M | 11.77M | 9.66M | 11.71M | 8.29M | 10.11M | 7.21M |
Research & Development | 91.18M | 108.69M | 116.27M | 174M | 54.08M | 44.17M | 25.65M | 68.74M | 71.09M | 71.24M | 70.64M | 70.95M | 68.61M | 62.15M | 70.74M | 68.27M | 58.5M | 47.93M | 52.89M | 54.87M | 51.63M | 45.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 380.55M | 377.21M | 356.24M | 383.12M | 250.94M | 212.05M | 166.87M | 176.33M | 176.54M | 152.04M | 117.18M | 98.53M | 86.45M | 78.34M | 85.3M | 80.41M | 70.27M | 57.59M | 64.6M | 63.16M | 61.74M | 52.98M |
Interest Expense | -7.94M | 7.82M | 8.3M | 7.45M | 3.26M | 3.3M | 3.5M | 3.68M | 3.66M | 3.84M | 3.97M | 3.5M | 2.9M | 2.34M | 1.68M | 1.5M | 780K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 420.56M | 404.06M | 380.69M | 401.24M | 260M | 216.56M | 170.32M | 178.48M | 177.18M | 152.04M | 117.18M | 98.53M | 86.45M | 78.34M | 85.3M | 80.41M | 70.27M | 57.59M | 64.6M | 63.16M | 61.74M | 52.98M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 29.15M | 29.03M | 22.43M | 22.48M | 22.21M | 22.09M | 21.93M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
Shares Outstanding (Diluted) | 29.15M | 29.03M | 22.43M | 22.48M | 22.21M | 22.09M | 21.93M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
EPS (Basic) | -1.99 | -3.25 | -2.57 | -5.08 | -1.90 | -3.32 | -2.71 | -4.92 | -7.10 | -7.38 | -5.68 | -5.34 | -4.69 | -4.23 | -4.98 | -4.75 | -4.14 | -3.36 | -3.78 | -3.79 | -3.72 | -3.32 |
EPS (Diluted) | -1.99 | -3.25 | -2.57 | -5.08 | -1.90 | -3.32 | -2.71 | -4.92 | -7.10 | -7.38 | -5.68 | -5.34 | -4.69 | -4.23 | -4.98 | -4.75 | -4.14 | -3.36 | -3.78 | -3.79 | -3.72 | -3.32 |
EBITDA | -56.31M | -86.19M | -49.89M | -106.38M | -38.64M | -69.56M | -55.55M | -102.99M | -148.05M | -143.54M | -108.08M | -95.1M | -82.77M | -74.44M | -84.09M | -79.57M | -69.84M | -57.41M | -64.44M | -63M | -61.56M | -52.87M |
EBIT | -56.31M | -86.57M | -50.28M | -106.74M | -39.02M | -69.94M | -55.92M | -103.29M | -148.32M | -143.7M | -108.22M | -95.24M | -82.9M | -74.56M | -84.22M | -79.7M | -69.95M | -57.52M | -64.55M | -63.1M | -61.65M | -52.98M |
Depreciation & Amortization | n/a | 386K | 392K | 358K | 377K | 379K | 363K | 298K | 267K | 168K | 142K | 135K | 126K | 124K | 129K | 121K | 110K | 107K | 106K | 97K | 89K | 113K |
Add to Watchlist
Select watchlists to add or remove MDGL